Epistemis

Palpable abdominal mass

Specialty: Gastrointestinal.

  • Palpable intra-abdominal tumor
  • palpable abdominal lump
  • palpable mass in abdomen

Why it occurs

  • Colorectal adenocarcinoma (especially in the right colon or cecum, where the tumors usually reach large dimensions before generating obstructive symptoms)
  • Splenomegaly or giant hepatomegaly secondary to myeloproliferative disorders, cirrhosis with congestion or lymphoma
  • Large diameter abdominal aortic aneurysm (expanding pulsatile mass located in the mesogastrium or epigastrium)
  • Pancreatic pseudocyst post-acute pancreatitis or intra-abdominal abscess (diverticular, appendicular or tuberculous)
  • Giant ovarian cyst or large-volume pedunculated uterine fibroid in the pelvis and lower abdomen.

Initial workup

CT of the abdomen and pelvis with double contrast (oral and intravenous with arterial and venous phase; definitive study of diagnostic choice to specify origin, vascularization and extension of the mass) | Abdominal ultrasound (useful to differentiate between cystic, solid or vascular masses in the first instance) | Colonoscopy or upper gastrointestinal endoscopy if origin in the gastrointestinal lumen is suspected | Determination of tumor markers (CEA, CA 19-9, AFP, CA 125) and general analysis with blood count and kidney function.

red flags

Painful pulsating abdominal mass in the midline (suggests aortic aneurysm in the phase of rapid expansion or rupture), signs of diffuse peritoneal irritation with hemodynamic instability, refractory fever, extreme weight loss or rapid onset conjunctival jaundice.

Standard management

  • Broad-spectrum intravenous antibiotic therapy if an inflammatory mass or intra-abdominal abscess is confirmed — piperacillin/tazobactam 4.5 g IV every 6 hours, or combination of ceftriaxone 2 g IV every 24 hours plus metronidazole 500 mg IV every 8 hours
  • Intravenous analgesics with central or peripheral action — metamizole 1-2 g IV or fentanyl, avoiding NSAIDs due to the risk of gastrointestinal bleeding or associated renal failure
  • Enteral or parenteral nutritional support in patients with obstructive masses or tumor cachexia.

Educational guidance for study. It is NOT a prescription recommendation. The actual choice depends on the cause, the patient, and current guidelines.

Area
Gastrointestinal
Listed causes
5
Treatment options
3
Download Epistemis